WallStSmart
FULC

Fulcrum Therapeutics Inc

NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY

$6.96
+9.50% today

Updated 2026-06-05

Market cap
$245.88M
P/E ratio
P/S ratio
2.66x
EPS (TTM)
$-1.15
Dividend yield
52W range
$3 – $16
Volume
1.7M

Fulcrum Therapeutics Inc (FULC) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201720182019202020212022202320242025
Total assets$4.34M$85.77M$110.44M$129.58M$235.00M$226.69M$257.69M$260.72M$366.28M
Cash & equivalents$407000.00$72.80M$96.71M$57.05M$35.41M$35.10M$25.56M$58.21M$197.53M
Current assets$1.34M$74.09M$100.08M$112.91M$226.00M$207.52M$242.20M$249.92M$357.48M
Total liabilities$3.02M$9.77M$23.29M$34.40M$23.46M$27.74M$22.50M$17.68M$17.28M
Current liabilities$2.79M$4.23M$12.14M$26.73M$19.20M$16.73M$13.68M$11.04M$13.05M
Long-term debt$0.00$0.00
Shareholder equity$1.32M$76.00M$87.15M$95.18M$211.54M$198.94M$235.19M$243.03M$349.00M
Retained earnings$-35.54M$-68.12M$-150.80M$-221.62M$-302.47M$-412.34M$-509.67M$-519.40M$-594.28M
Accounts receivable$39000.00$501000.00$111000.00$2.71M$4.11M$1.08M$2.25M$3.34M$1.07M
Inventory$734000.00$559000.00$2.98M$-2.78M$-473000.00$-473000.00
Goodwill$0.00$0.00

Frequently asked questions

How much free cash flow does FULC generate?

FULC produced $-60.38M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is FULC's balance sheet healthy?

FULC holds $197.53M in cash and equivalents against — in long-term debt, on $349.00M of shareholder equity. That debt is best read against the cash flow the business throws off each year.